Trials / Completed
CompletedNCT01801007
Pivotal Study of the FRED Stent System in the Treatment of Intracranial Aneurysms
Pivotal Study of the MicroVention Flow Re-Direction Endoluminal Device (FRED) Stent System in the Treatment of Intracranial Aneurysms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Microvention-Terumo, Inc. · Industry
- Sex
- All
- Age
- 22 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of the MicroVention Flow Redirection Intraluminal Device (FRED) system when used in the treatment of wide-necked intracranial aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Flow Re-Direction Endoluminal Device (FRED) |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2013-02-28
- Last updated
- 2021-03-08
- Results posted
- 2020-10-09
Locations
24 sites across 2 countries: United States, Japan
Source: ClinicalTrials.gov record NCT01801007. Inclusion in this directory is not an endorsement.